Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Cash-Poor Biotechs Should Get U.S. Money to Develop Medicine, Collins Says
Cash-Poor Biotechs Should Get U.S. Money to Develop Medicine, Collins Says
Cash-Poor Biotechs Should Get U.S. Money to Develop Medicine, Collins Says
Submitted by
admin
on July 8, 2010 - 8:56am
Source:
Bloomberg
News Tags:
biotechs
Headline:
Cash-Poor Biotechs Should Get U.S. Money to Develop Medicine, Collins Says
Do Not Allow Advertisers to Use My Personal information
